This signaling pathway, however, is inhibited following pressure-overload hypertrophy, likely mediated by enhanced signaling of CaMKII and p53, providing an explanation for the functional decompensation and adverse ventricular remodeling in β2-TG hearts after TAC. The gene discussed is TP53; the disease is persistent truncus arteriosus.